COMPANY PROFILE

GeneChem / 吉凯基因

Explore full profile

Gene research services and cell-therapy CDMO (plasmid, LV, CAR-T/TCR-T)

Pudong, ChinaFounded 2002Biotech & Life Sciences

Valuation $250–500M Last recorded · 2020

Headcount <100 Current team size

Total funding $50–100M Disclosed equity funding

Unlock exact values

About GeneChem / 吉凯基因

Shanghai GeneChem Medical Technology Co., Ltd. (吉凯基因) is a Zhangjiang-based gene technology company founded in 2002. It provides end-to-end genetic research services spanning proteomics and high-throughput sequencing for clinical investigators, plus GMP-like plasmid, lentiviral vector and CAR-T/TCR-T cell-therapy CDMO capabilities for IND-oriented programs. The company operates R&D labs, process-development suites and production facilities totaling tens of thousands of square meters and publicly states 500+ staff supporting research-to-translation workflows for hospitals and biotech sponsors in China.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2002
Headquarters: Pudong, China
Employees: 61
Open positions: None listed
Dealroom signal: 23.3/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Genetics and genomics, Biotech and Pharma, Hard Tech, DT and LS, science-based
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

3 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES COther financing	Apr 2020	$56M	$224M	Principle Capital · Shanghai Zhangjiang S&T Venture Capital	↗
SERIES COther financing	Mar 2019	$0	—	Undisclosed	—

Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

GeneChem / 吉凯基因 website traffic

Latest recorded traffic for GeneChem / 吉凯基因 is 2.8K monthly website visits, down 67.1% over the last three months. GeneChem / 吉凯基因's team grew 0% over the past year.

Latest monthly visits2.8K 3-month web change-67.1% 1-year team growth0%

Monthly website visitsMay 2018–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
HTHarness TherapeuticsA private biotechnology company, headquartered in Cambridge-UK, focused on the development of a novel class of therapeutic RNAs	Babraham, United Kingdom	Operational	5	$35M	$90M
LALarondePioneering a completely novel translatable RNA platform - Endless RNA (eRNA)	Cambridge, United States	Operational
ANAntegenesGenetic tests for personalized cancer risk prevention	Tartu, Estonia	Operational
C4C4UC4U Corporation is a developer of a genome editing technology	Suita-Shi, Japan	Operational
MTModalis TherapeuticsEpigenetic gene modulation therapies for genetic disorders	Cambridge, United States	Operational
EBEligo BioscienceEligo Bioscience is a biotechology company that develops a new class of biotherapeutics for microbiome precision-editing	Paris, France	Operational
PRProGeLifeDevelopment of drugs for the treatment of rare genetic aging diseases	Marseille, France	Operational
QUQurAlisBiotech company focused on developing precision solutions to cure amyotrophic lateral sclerosis	Cambridge, United States	Operational